In Brief: Enzon
Enzon: Randy Thurman elected as non-executive chairman of the board, succeeding co-founder and director Abraham Abuchowski. Thurman, most recently chairman and CEO of Corning Life Sciences, was previously president of Rhone-Poulenc Rorer Pharmaceuticals. Piscataway, N.J.-based Enzon also has created an R&D steering committee that will direct overall R&D strategy and report to Enzon President and CEO Peter Tombros...
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth